Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Menu

    Benzodiazepine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 730Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ashtonmanual.org Launches As Key Benzodiazepine Tapering Resource
    Ashtonmanual.org Launches As Key Benzodiazepine Tapering Resource

    27 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/27/3246717/0/en/AshtonManual-org-Launches-as-the-Definitive-Resource-for-Safe-Evidence-Based-Benzodiazepine-Tapering.html

    GLOBENEWSWIRE
    27 Feb 2026
    Share Share
    Polyrizon Expands Drug Delivery With Preclinical Epilepsy Study
    Polyrizon Expands Drug Delivery With Preclinical Epilepsy Study

    25 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/25/3049145/0/en/Polyrizon-Expands-Drug-Delivery-Innovation-with-Preclinical-Studies-for-Epilepsy-Rescue-Treatment.html

    GLOBENEWSWIRE
    25 Mar 2025
    Share Share
    Crossject Elaborates On ZEPIZURE Potential In Light Of RAMPART Study
    Crossject Elaborates On ZEPIZURE Potential In Light Of RAMPART Study

    26 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/26/2904232/0/en/Crossject-elaborates-on-ZEPIZURE-potential-in-light-of-landmark-RAMPART-study-and-its-own-recently-published-bioequivalence-study.html

    GLOBENEWSWIRE
    26 Jun 2024
    Share Share
    Benzodiazepine use linked with increased miscarriage risk, says new study
    Benzodiazepine use linked with increased miscarriage risk, says new study

    29 Dec 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/benzodiazepine-use-linked-with-increased-miscarriage-risk-says-new-study/articleshow/106375409.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    29 Dec 2023
    Share Share
    Aquestive offloads film formulation seizure drug to Assertio
    Aquestive offloads film formulation seizure drug to Assertio

    31 Oct 2022

    // Nick Paul Taylor FIERCEPHARMA

    https://www.fiercepharma.com/pharma/aquestive-offloads-film-formulation-seizure-drug-assertio-securing-cash-epinephrine-rd

    Nick Paul Taylor FIERCEPHARMA
    31 Oct 2022
    Share Share
    Benzodiazepine Withdrawal Tied to Serious Long-Term Harms
    Benzodiazepine Withdrawal Tied to Serious Long-Term Harms

    12 Apr 2022

    // PSYCHOLOGUTODAY

    https://www.psychologytoday.com/gb/blog/side-effects/202205/benzodiazepine-withdrawal-tied-serious-long-term-harms

    PSYCHOLOGUTODAY
    12 Apr 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.